• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    The development of anti-angiogenic heparan sulfate oligosaccharides.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Jayson, Gordon C
    Miller, G
    Hansen, S
    Barath, M
    Gardiner, J
    Avizienyte, Egle
    Affiliation
    Institute of Cancer Sciences, Christie Hospital and University of Manchester, Withington, Manchester M20 4BX
    Issue Date
    2014-12-01
    
    Metadata
    Show full item record
    Abstract
    Angiogenesis has emerged as a novel target for anti-cancer therapies through randomized clinical trials that tested the benefit of adding vascular endothelial growth factor (VEGF) inhibitors to conventional cytotoxic therapies. However, despite improvements in the progression-free survival, the benefit in overall survival is modest. Tumour angiogenesis is regulated by a number of angiogenic cytokines. Thus innate or acquired resistance to VEGF inhibitors can be caused, at least in part, through expression of other angiogenic cytokines, including fibroblast growth factor 2 (FGF2), interleukin 8 (IL-8) and stromal-cell-derived factor 1α (SDF-1α), which make tumours insensitive to VEGF signalling pathway inhibition. The majority of angiogenic cytokines, including VEGF-A, FGF2, IL-8 and SDF-1α, manifest an obligate dependence on heparan sulfate (HS) for their biological activity. This mandatory requirement of angiogenic cytokines for HS identifies HS as a potential target for novel anti-angiogenic therapy. Targeting multiple angiogenic cytokines with HS mimetics may represent an opportunity to inhibit tumour angiogenesis more efficiently. Our published studies and unpublished work have demonstrated the feasibility of generating synthetic HS fragments of defined structure with biological activity against a number of angiogenic cytokines.
    Citation
    The development of anti-angiogenic heparan sulfate oligosaccharides. 2014, 42 (6):1596-600 Biochem Soc Trans
    Journal
    Biochemical Society Transactions
    URI
    http://hdl.handle.net/10541/336212
    DOI
    10.1042/BST20140229
    PubMed ID
    25399576
    Type
    Article
    Language
    en
    ISSN
    1470-8752
    ae974a485f413a2113503eed53cd6c53
    10.1042/BST20140229
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Synthetic heparan sulfate oligosaccharides inhibit endothelial cell functions essential for angiogenesis.
    • Authors: Cole CL, Hansen SU, Baráth M, Rushton G, Gardiner JM, Avizienyte E, Jayson GC
    • Issue date: 2010 Jul 21
    • Heparin oligosaccharides: inhibitors of the biological activity of bFGF on Caco-2 cells.
    • Authors: Jayson GC, Gallagher JT
    • Issue date: 1997
    • Endothelial heparan sulfate 6-O-sulfation levels regulate angiogenic responses of endothelial cells to fibroblast growth factor 2 and vascular endothelial growth factor.
    • Authors: Ferreras C, Rushton G, Cole CL, Babur M, Telfer BA, van Kuppevelt TH, Gardiner JM, Williams KJ, Jayson GC, Avizienyte E
    • Issue date: 2012 Oct 19
    • Novel anti-angiogenic therapies for malignant gliomas.
    • Authors: Norden AD, Drappatz J, Wen PY
    • Issue date: 2008 Dec
    • Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    • Authors: Gacche RN, Meshram RJ
    • Issue date: 2013 Nov
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.